Dasiglucagon is a potent glucagon receptor agonist used in the treatment of severe hypoglycemia. It activates the glucagon receptor to stimulate glucose production and release from the liver, providing a rapid and effective response in emergency situations.
CAT No: R2068
Dasiglucagon is a synthetic peptide analog of human glucagon, engineered to provide enhanced stability and solubility for research applications. As a member of the glucagon family of peptide hormones, it plays a pivotal role in glucose homeostasis by stimulating hepatic glucose output through activation of the glucagon receptor. Its optimized molecular structure allows for improved performance in experimental settings, making it a valuable tool for investigating glucagon receptor biology, metabolic regulation, and peptide pharmacology. Dasiglucagon's unique properties have positioned it as a preferred reagent in studies requiring robust and reproducible glucagon receptor activation, especially where conventional glucagon's instability may be a limiting factor.
Peptide receptor research: Dasiglucagon is extensively utilized in studies focused on the glucagon receptor (GCGR), a class B G protein-coupled receptor central to glucose metabolism. Its chemical stability and receptor-selective activity allow researchers to dissect GCGR signaling pathways with high precision. By serving as a reliable agonist, it facilitates the elucidation of downstream signaling events, receptor desensitization kinetics, and ligand-receptor interaction dynamics, thereby advancing the understanding of peptide hormone-receptor pharmacology.
Metabolic pathway analysis: The compound serves as a critical tool in metabolic research, particularly in the characterization of hepatic glucose production and glycogenolysis. Its ability to robustly stimulate glucose output in hepatocyte models enables detailed investigation of the molecular mechanisms underlying glucagon-mediated metabolic responses. This supports the development of new insights into the regulation of energy balance, gluconeogenesis, and the interplay between insulin and glucagon signaling in physiological and pathophysiological states.
Peptide stability and formulation studies: Due to its engineered resistance to degradation and superior solubility profile, dasiglucagon is frequently employed in comparative studies evaluating peptide formulation strategies. Researchers leverage its properties to assess the impact of sequence modifications on peptide integrity, aggregation, and shelf-life. Such studies are instrumental in the rational design of next-generation peptide analogs with improved pharmaceutical attributes for research use.
Analytical assay development: The reliable activity and well-characterized bioanalytical profile of this glucagon analog make it an ideal standard in the development and validation of quantitative assays. It is often used as a reference compound in immunoassays, receptor-binding studies, and bioactivity assays, ensuring accuracy and reproducibility in the measurement of glucagon-like peptides and related analytes. The availability of a stable, synthetic standard supports high-throughput screening and robust assay performance in both academic and industrial research environments.
Peptide signaling modulation: Dasiglucagon's defined receptor selectivity and potent agonist activity enable precise modulation of cyclic AMP (cAMP) signaling cascades in cellular models. By providing a consistent and reproducible means of activating glucagon-dependent pathways, it facilitates the study of cross-talk between hormonal signaling networks, second messenger dynamics, and the regulation of gene expression in response to peptide hormone stimulation. These capabilities are essential for advancing knowledge in signal transduction, metabolic regulation, and peptide-based research tool development.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More